Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heuser

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
Leukemia|January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study GroupN Jahn, M Agrawal, L Bullinger, et al.
Leukemia|August 23, 2017
RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivoN Jyotsana, A Sharma, A Chaturvedi, et al.
Leukemia|February 8, 2014
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantationV Panagiota, F Thol, B Markus, et al.
Leukemia|February 1, 2017
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureM Wattad, D Weber, K Döhner, et al.
Blood Cancer Journal|December 10, 2016
MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemiaK Krowiorz, J Ruschmann, C Lai, et al.
Leukemia|June 24, 2017
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemiaV I Gaidzik, D Weber, P Paschka, et al.
Leukemia|March 21, 2015
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5qM Heuser, M Meggendorfer, M M A Cruz, et al.
Leukemia|May 4, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
Leukemia|July 5, 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study groupF Theis, A Corbacioglu, V I Gaidzik, et al.
Leukemia|November 3, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Leukemia|January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study GroupN Jahn, M Agrawal, L Bullinger, et al.
Leukemia|August 23, 2017
RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivoN Jyotsana, A Sharma, A Chaturvedi, et al.
Leukemia|February 8, 2014
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantationV Panagiota, F Thol, B Markus, et al.
Leukemia|February 1, 2017
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureM Wattad, D Weber, K Döhner, et al.
Blood Cancer Journal|December 10, 2016
MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemiaK Krowiorz, J Ruschmann, C Lai, et al.
Leukemia|June 24, 2017
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemiaV I Gaidzik, D Weber, P Paschka, et al.
Leukemia|March 21, 2015
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5qM Heuser, M Meggendorfer, M M A Cruz, et al.
Leukemia|May 4, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
Leukemia|July 5, 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study groupF Theis, A Corbacioglu, V I Gaidzik, et al.
Leukemia|November 3, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
Pageof 16